EFPIA HCP/HCO and R&D Reporting


Introduction

Interactions between pharmaceutical companies and healthcare professionals (HCPs) and healthcare organizations (HCOs) have a profound and positive influence on the quality of patient treatments and value of future research.

To ensure that the interactions meet the high integrity standards that patients, governments and other stakeholders expect, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and its member associations and companies have adopted codes and guidelines.

The EFPIA Disclosure Code was created to foster greater transparency and build greater trust between the pharmaceutical industry, the medical community and wider society.

As an EFPIA-member Merck is fully committed to the efforts of strengthening these relationships and to protect their integrity. Therefore the company documents and discloses all Transfers of Value to Healthcare Professionals, and Healthcare Organizations as well as Transfers of Value arising out of Research and Development (R&D) activities in every EFPIA country where Merck operates.

Disclosure is made on an annual basis and the reporting period covers a full calendar year. First reporting period is the year 2015.

Self Certification Letter

Merck certifies that it has made its best efforts to comply with the EFPIA Disclosure Code in full, in line with applicable national laws and regulations. For further information please see the Self-Certification Letter, signed by the Chairman of the Executive Board and CEO.

Disclaimer

Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to HCPs/HCOs our company is collaborating / has relationships with, following the objectives and provisions included in the applicable codes. Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable codes that our company signed off to.

These publications do not grant a general permission for those accessing our website or the national platforms to undertake additional processing of the healthcare professionals’ data.

For a good understanding of the reporting included in our disclosures as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.

2017

Romania

Romania

UK

UK

2016

Austria

Austria

Belgium

Belgium

Bulgaria

Bulgaria

Croatia

Croatia

Czech

Czech

Denmark

Denmark

Estonia

Estonia

Finland

Finland

France

France

Germany

Germany

Greece

Greece

Hungary

Hungary

Ireland

Ireland

Italy

Italy

Latvia

Latvia

Lithuania

Lithuania

Luxembourg

Luxembourg

Netherlands

Netherlands

Norway

Norway

Poland

Poland

Portugal

Portugal

Romania

Romania

Russia

Russia

Serbia

Serbia

Slovakia

Slovakia

Slovenia

Slovenia

Spain

Spain

Switzerland

Switzerland

Turkey

Turkey

UK

UK

2015

Austria

Austria

Belgium

Belgium

Bulgaria

Bulgaria

Croatia

Croatia

Czech

Czech

Denmark

Denmark

Estonia

Estonia

Finland

Finland

France

France

Germany

Germany

Greece

Greece

Hungary

Hungary

Ireland

Ireland

Italy

Italy

Latvia

Latvia

Lithuania

Lithuania

Netherlands

Netherlands

Norway

Norway

Poland

Poland

Portugal

Portugal

Romania

Romania

Russia

Russia

Serbia

Serbia

Slovakia

Slovakia

Slovenia

Slovenia

Spain

Spain

Switzerland

Switzerland

Turkey

Turkey

UK

UK

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement